This inventor holds 1 USPTO granted patent. Top assignees: Selfusion Inc., Waseda University. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2011
Title: Innovations of Yuji Morimoto in Tissue Decellularization
Introduction
Yuji Morimoto is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of tissue engineering, particularly in the area of decellularization methods for transplantable tissues. His innovative approach aims to enhance the biocompatibility of living organism tissues used in transplants.
Latest Patents
Morimoto holds a patent for a method of decellularizing tissues. This method involves using a cell removing solution to eliminate original cells from living organism tissues, such as heart valves, taken from animals. The solution is provided with a flow that approximates the bloodstream of the transplant recipient. The living organism tissue is immersed in this flow, which is essential for effective decellularization. During the immersion process, the tissue is rotated and irradiated with microwave energy. This technique ensures that original cells are removed uniformly and reliably, thereby enhancing the biocompatibility of the tissue after transplantation.
Career Highlights
Throughout his career, Yuji Morimoto has worked with esteemed institutions, including Waseda University and Selfusion Inc. His work has been pivotal in advancing the methodologies used in tissue transplantation and engineering.
Collaborations
Morimoto has collaborated with notable colleagues such as Mitsuo Umezu and Kiyotaka Iwasaki. Their combined expertise has contributed to the development of innovative solutions in the field of tissue engineering.
Conclusion
Yuji Morimoto's contributions to the field of tissue decellularization represent a significant advancement in transplant technology. His innovative methods have the potential to improve the outcomes of tissue transplants, making a lasting impact on medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile